Fiji vs Israel: The number of people with susceptibility test result for rifampicin
Fiji
127
in 2021
Israel
103
in 2021
Fiji rank
105th
Israel rank
108th
The number of people with susceptibility test result for rifampicin over time
- Fiji
- Israel
How they compare
Fiji currently reports 127 against 103 in Israel, a difference of 24.
That makes Fiji's figure about 1.2 times Israel's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Fiji ahead.
Fiji ranks 105th and Israel ranks 108th of 155 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 139 | 129.33 | 9.67 | Fiji |
| 2020s | 123.5 | 96 | 27.5 | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Fiji or Israel?
- Fiji, at 127 against 103 in Israel as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Fiji and Israel?
- 24, with Fiji ahead.
- How many years of comparable data are there for Fiji and Israel?
- 5 years are reported by both, from 2017 to 2021.
- How do Fiji and Israel rank globally for the number of people with susceptibility test result for rifampicin?
- Fiji ranks 105th and Israel ranks 108th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.